So thats a reason for some optimism and for really wanting to move this area of clinical research forward. Hendershot and others are quick to point out that more studies, particularly on large numbers of people, need to be done
IVIM has shown awareness of this by also offering brand-name prescriptions, which provides a fallback option if compounded availability changes
this was shown to protect against Ang II-induced injury in the heart and aorta, potentially associated with inhibition of NOX4 expression and preservation of mitochondrial integrity, reduced the protein levels of NADPH oxidase 4 (NOX4) and TGF1 and expression of monocyte chemoattractant protein 1, and attenuated the proliferation of myofibroblasts culminating in reduced aortic wall thickness [81]
Research shows this compound mimics ghrelin activity, binds to the growth hormone secretagogue receptor and stimulates more growth hormone production with minimal impact on other hormonal systems
Taylor Cottle, PhD Serial Biotech Entrepreneur| PhD, John Hopkins University